Study shows high efficacy rate for fecal transplants

04/13/2012 | Medscape (free registration)

Fecal transplants resolved recurrent Clostridium difficile infection in more than 90% of patients, according to a report in the American Journal of Gastroenterology. Montefiore Medical Center researchers said the study included long-term follow-up with patients who had followed an average of five unsuccessful courses of traditional treatments without success before having fecal transplantation. "FMT is a rational, durable, safe, and acceptable treatment option for patients with recurrent C. difficile infection," Dr. Lawrence J. Brandt and colleagues wrote.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC